Navigation Links
Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
Date:7/28/2008

ROCKVILLE, Md., July 28 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today the receipt of a not approvable letter from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application for iloperidone, an investigational atypical antipsychotic that was reviewed for the treatment of schizophrenia.

The FDA stated that Vanda had demonstrated the effectiveness of iloperidone at 24 mg/day in the 3101 study for which the company reported results in December, 2006, and that the efficacy was similar to the active comparator, ziprasidone (Geodon(R), Pfizer Inc.). In addition, the FDA also stated that iloperidone was superior to placebo in patients with schizophrenia at doses of 12-16 mg/day and 20-24 mg/day in a prior study. However, the FDA expressed concern about the efficacy of iloperidone in patients with schizophrenia relative to the active comparator, risperidone (Risperdal(R), Johnson & Johnson), used in prior studies. The FDA indicated that it would require an additional trial comparing iloperidone to placebo and including an active comparator such as olanzapine (Zyprexa(R), Eli Lilly & Company) or risperidone in patients with schizophrenia to demonstrate the compound's efficacy further. The FDA also stated that it would require Vanda to obtain additional safety data for patients at a dose range of 20 to 24 mg/day.

"We are disappointed by this response, but will meet with the FDA to discuss this decision further," said Mihael H. Polymeropoulos, M.D., Vanda's President and CEO.

Vanda has put on hold all iloperidone-related activities pending further review.

As of June 30, 2008, Vanda's cash, cash equivalents, and marketable securities totaled approximately $65.6
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
2. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
3. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
4. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
5. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
6. Vanda Pharmaceuticals to Present at Natixis Bleichroeders Hidden Gems Conference
7. Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
8. New Natural Product from Zurich Pharmaceuticals Downs Appetite
9. AUDIO from Medialink and Duramed Pharmaceuticals: Not Your Mothers Menopause
10. Genesis Pharmaceuticals Announces New Board Member and Forms Committees
11. Sound Pharmaceuticals Receives Additional DoD Funding for Its Hearing Regeneration Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... By Dennis Thompson ... -- Very sick children with complex chronic illnesses can receive ... a "medical home," with easy access to a team of ... were less likely to become seriously ill and need either ... received treatment at an enhanced medical home clinic at the ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... , , INCLINE VILLAGE, Nev., ... today reported financial results for the second quarter ended June 30, 2009. ... second quarter of 2009 were $125.9 million, an 18 percent increase from ... primarily to royalty revenues driven by higher product sales of Avastin(R), and ...
... , , , HAYWARD, ... a global leader in the medical aesthetics market, today announced results for ... $27.4 million, an increase of approximately $9.5 million, or 53%, as compared ... the acquisition of Reliant Technologies, Inc. on December 23, 2008. The company ...
... , , , ... GXDX ), a specialized laboratory services provider, today reported revenues of ... $3.7 million benefit from changes in accounting estimates resulting primarily from ... increased 62.8% over revenues of $27.8 million for the comparable period ...
... 30 Nephros, Inc. (OTC Bulletin Board: NEPH), a medical ... infection control, and water purification, today reported that it has ... and warrants to purchase additional common stock for aggregate proceeds ... is pleased to have completed this financing, which was led ...
... , STEWARTVILLE, Minn., July 30 Rochester Medical ... quarter ended June 30, 2009. , , The Company reported ... quarter of last year. The Company also reported net loss of $77,000 ... $312,000 or $.02 per diluted share for the same period of last year. ...
... , , ... GPRO ) today reported financial results for the second ... and record sexually transmitted disease (STD), clinical diagnostics and total product ... the second quarter of 2009 as a good performance from our ...
Cached Medicine News:Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 2Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 3Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 4Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 5Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 6Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 7Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 8Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 9Health News:Solta Medical Reports Strong Second Quarter 2009 Results 2Health News:Solta Medical Reports Strong Second Quarter 2009 Results 3Health News:Solta Medical Reports Strong Second Quarter 2009 Results 4Health News:Solta Medical Reports Strong Second Quarter 2009 Results 5Health News:Solta Medical Reports Strong Second Quarter 2009 Results 6Health News:Solta Medical Reports Strong Second Quarter 2009 Results 7Health News:Solta Medical Reports Strong Second Quarter 2009 Results 8Health News:Solta Medical Reports Strong Second Quarter 2009 Results 9Health News:Solta Medical Reports Strong Second Quarter 2009 Results 10Health News:Solta Medical Reports Strong Second Quarter 2009 Results 11Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 2Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 3Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 4Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 5Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 6Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 7Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 8Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 9Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 10Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 11Health News:Nephros, Inc. Completes $1.25 Million Private Placement 2Health News:Nephros, Inc. Completes $1.25 Million Private Placement 3Health News:Rochester Medical Reports Third Quarter Results 2Health News:Rochester Medical Reports Third Quarter Results 3Health News:Rochester Medical Reports Third Quarter Results 4Health News:Rochester Medical Reports Third Quarter Results 5Health News:Rochester Medical Reports Third Quarter Results 6
(Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
(Date:12/24/2014)... SAN DIEGO , Dec. 24, 2014 /PRNewswire/ ... the West, developing the proprietary Natural Killer (NK) ... announces that Dr. Patrick Soon-Shiong , NantWorks ... into a definitive agreement to purchase approximately $48 ... In connection with the investment, he will be ...
(Date:12/24/2014)... 23, 2014 PuraMed BioScience®, Inc., (OTC Pink: ... medicinal and healthcare products, announced it received the initial ... hemp-based, advanced headache relief product, for planned distribution to ... Colorado , Washington State , ... the MigraPure H Advanced headache relief gel formulation completed, ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Sonix CEP provides Emergency Medicine practitioners with high performance imaging in a compact, portable system that boots up in seconds and runs on rechargeable battery up to 30 minutes so it's alwa...
MPatch® is a topical adhesive wound dressing for the local management and control of bleeding from vascular access sites and percutaneous catheters....
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
Medicine Products: